Study Summary: This study is looking at how well a drug called muvalaplin works to lower the risk of heart problems in people with high levels of something called lipoprotein(a) (pronounced "lipoprotein-a"). Lipoprotein(a) is a type of fat in the blood, and having too much can cause heart attacks and strokes.
Who Can Join: To participate, you need to have high lipoprotein(a) levels (175 nmol/L or more) and either have had a heart problem before or be at risk for one. Risk factors include things like coronary artery disease or diabetes.
Who Cannot Join: You cannot join if you had a major heart event or surgery recently, plan to have a heart procedure soon, have severe heart failure, or have certain other health issues like uncontrolled high blood pressure or severe kidney problems.
3 Key Points:
- The study lasts for a set period, requiring regular visits to the clinic.
- Participants might receive muvalaplin or a placebo (a fake treatment) to compare results.
- There's a focus on safety, but some risks might be involved with participation.
How understandable was the trial content above?
Hard to understand
Easy to understand